Sirius Venture Partners
Biebricher Allee 22, Wiesbaden, Hessen, 65187, Germany
Overview
Sirius Venture Partners GmbH is a venture capital firm specializing in seed, start-up, mid venture, and early venture investments. The firm seeks to invest between €0.15 million ($0.21 million) and €1.5 million ($2.1 million) in its portfolio companies. It would consider syndicated investments with private and public partners of up to €5 million ($ 6.95 million). The company typically acts as a lead or co-lead investor, takes a minority stake and a seat on the board or committee of its portfolio company. The firm typically exits its investment through IPO or trade sale. Sirius Venture Partners GmbH was founded in 2004 and is based in Wiesbaden, Germany with an additional office in Düsseldorf, Germany.
- Total investments
- 3
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 5
Sector focus
- Finance
- Venture Capital
Investment portfolio
- evocatal
Participated · Series B · Jun 2013
evocatal develops and produces enzymes and fine chemicals, supplying biocatalysts used in the synthesis of pharmaceutical compounds, chemical intermediates and in the manufacture and refinement of consumer goods such as textiles, adhesives, detergents and cosmetics. Led by CEO Dr. Thorsten Eggert, the company is based in Düsseldorf, Germany. In June 2013 evocatal closed a €3.5m Series B funding round. The company intends to use the funds to extend its technology platform and broaden its product portfolio. Investors in the round included existing backers Roland Oetker, High‑Tech Gründerfonds (HTGF), Sirius Seedfonds Düsseldorf (SSFD) and business angel Prof. Riesner, alongside new investors Nrw.Bank and Lanxess. The firm previously raised €2m in growth financing in 2010. evocatal specialises in developing new enzymes and enzyme-based chemical processes, including a portfolio of proprietary biocatalysts (evozymes®). The company has commercialized a fluorescent protein for anaerobic applications used in biotechnological R&D. It also develops novel expression and secretion systems for enzyme production and innovative screening methods. The recent financing is intended to support the development of new products. The company serves the pharmaceutical and fine-chemical sectors with low-molecular-weight compound synthesis expertise. evocatal was founded in 2006 and is based in the Life Science Center of Düsseldorf.
- Fashionette
Participated · Equity · Feb 2011
Luxury Fashion Trade GmbH operates fashionette.de, an online retailer offering luxury handbags, evening gowns, jewelry and sunglasses from a selection of over 60 top designers. The site features new and classic articles available each week through its e-commerce platform. Founded in 2008 by Fabio Labriola, Ronald Reschke and Dr. Sebastian Siebert and based in Germany, the company focuses on the luxury accessories market. It raised €1.5m in equity funding to support growth and platform improvements. The funds are intended to finance international expansion—especially into the UK and Switzerland—enhancements to the buyer online experience, and a comprehensive website relaunch planned shortly.